Cargando…

Host Transcriptional Response to Ebola Virus Infection

Ebola virus disease (EVD) is a serious illness that causes severe disease in humans and non-human primates (NHPs) and has mortality rates up to 90%. EVD is caused by the Ebolavirus and currently there are no licensed therapeutics or vaccines to treat EVD. Due to its high mortality rates and potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Speranza, Emily, Connor, John H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620561/
https://www.ncbi.nlm.nih.gov/pubmed/28930167
http://dx.doi.org/10.3390/vaccines5030030
_version_ 1783267611812823040
author Speranza, Emily
Connor, John H
author_facet Speranza, Emily
Connor, John H
author_sort Speranza, Emily
collection PubMed
description Ebola virus disease (EVD) is a serious illness that causes severe disease in humans and non-human primates (NHPs) and has mortality rates up to 90%. EVD is caused by the Ebolavirus and currently there are no licensed therapeutics or vaccines to treat EVD. Due to its high mortality rates and potential as a bioterrorist weapon, a better understanding of the disease is of high priority. Multiparametric analysis techniques allow for a more complete understanding of a disease and the host response. Analysis of RNA species present in a sample can lead to a greater understanding of activation or suppression of different states of the immune response. Transcriptomic analyses such as microarrays and RNA-Sequencing (RNA-Seq) have been important tools to better understand the global gene expression response to EVD. In this review, we outline the current knowledge gained by transcriptomic analysis of EVD.
format Online
Article
Text
id pubmed-5620561
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56205612017-10-03 Host Transcriptional Response to Ebola Virus Infection Speranza, Emily Connor, John H Vaccines (Basel) Review Ebola virus disease (EVD) is a serious illness that causes severe disease in humans and non-human primates (NHPs) and has mortality rates up to 90%. EVD is caused by the Ebolavirus and currently there are no licensed therapeutics or vaccines to treat EVD. Due to its high mortality rates and potential as a bioterrorist weapon, a better understanding of the disease is of high priority. Multiparametric analysis techniques allow for a more complete understanding of a disease and the host response. Analysis of RNA species present in a sample can lead to a greater understanding of activation or suppression of different states of the immune response. Transcriptomic analyses such as microarrays and RNA-Sequencing (RNA-Seq) have been important tools to better understand the global gene expression response to EVD. In this review, we outline the current knowledge gained by transcriptomic analysis of EVD. MDPI 2017-09-20 /pmc/articles/PMC5620561/ /pubmed/28930167 http://dx.doi.org/10.3390/vaccines5030030 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Speranza, Emily
Connor, John H
Host Transcriptional Response to Ebola Virus Infection
title Host Transcriptional Response to Ebola Virus Infection
title_full Host Transcriptional Response to Ebola Virus Infection
title_fullStr Host Transcriptional Response to Ebola Virus Infection
title_full_unstemmed Host Transcriptional Response to Ebola Virus Infection
title_short Host Transcriptional Response to Ebola Virus Infection
title_sort host transcriptional response to ebola virus infection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620561/
https://www.ncbi.nlm.nih.gov/pubmed/28930167
http://dx.doi.org/10.3390/vaccines5030030
work_keys_str_mv AT speranzaemily hosttranscriptionalresponsetoebolavirusinfection
AT connorjohnh hosttranscriptionalresponsetoebolavirusinfection